Dilip Shanghvi
Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries, India's largest drugmaker. Under his leadership, the company has significantly expanded its global footprint, with a notable reliance on the US market, which accounted for 32% of its total revenue in fiscal 2024. Shanghvi has been vocal about the potential impact of proposed tariffs on pharmaceutical imports, indicating that any increased costs would likely be passed on to consumers. His strategic vision has positioned Sun Pharma as a key player in the global pharmaceutical industry, particularly in the generic drug sector.
Born on Jun 01, 1955 (69 years old)
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Dilip Shanghvi, chairman of Sun Pharma, expressed concerns that tariffs do not justify relocating manufacturing to the US.
5
India:
Managing Director Dilip Shanghvi stated earlier this week that if the proposed tariffs are imposed, the additional costs will be passed on to consumers.
5